Codes / ICD10CM / F19.21

F19.21 Other psychoactive substance dependence, in remission

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Psychoactive Substance Dependence, in Remission
  • ICD-10 Code: F19.21

Summary

Other psychoactive substance dependence, in remission, refers to a condition where an individual previously met criteria for dependence on non-classified psychoactive substances (excluding alcohol, opioids, or cannabis) but has not experienced clinically significant impairment or symptoms for a sustained period. This state indicates a period of stability without active substance use or related issues.

Causes

The condition arises from prior chronic use of psychoactive substances that alter brain function, leading to dependence. Factors such as psychological stress, trauma, or social influences may have contributed to the initial substance use and subsequent dependence. Remission occurs when these factors are managed, and substance use is discontinued.

Risk Factors

  • Genetic predisposition to addiction
  • Co-occurring mental health disorders (e.g., anxiety, depression)
  • Early exposure to psychoactive substances
  • Environmental access to substances or social norms supporting use

Symptoms

  • Absence of active substance use or cravings
  • No withdrawal symptoms or impairment in daily functioning
  • Sustained period of stability without relapse

Diagnosis

Diagnosis involves a thorough medical and psychological evaluation, including patient history of substance use and current status. Clinicians assess for sustained remission, typically defined by a lack of dependence symptoms over a specified period, and confirm no recent substance use or related issues.

Treatment Options

  • Ongoing monitoring to prevent relapse
  • Supportive therapy or counseling to maintain sobriety
  • Addressing underlying mental health or social factors

Prognosis and Follow-Up

Prognosis is generally positive with sustained remission, but ongoing follow-up is essential to monitor for potential relapse. Regular check-ins with healthcare providers help ensure continued stability and address any emerging risks.

Complications

  • Risk of relapse if triggers or underlying issues are not managed
  • Potential for co-occurring disorders to resurface without proper support

Lifestyle & Prevention

  • Avoiding environments or triggers associated with substance use
  • Engaging in healthy coping mechanisms (e.g., exercise, mindfulness)
  • Building a strong support network to reinforce sobriety

When to Seek Professional Help

Seek help if there are signs of relapse, such as renewed cravings, withdrawal symptoms, or a return to substance use. Early intervention can prevent a full recurrence of dependence.

Tips for Medical Coders

Document the duration of remission and any supporting evidence (e.g., patient self-reports, clinical assessments) to confirm the remission status. Ensure the code F19.21 is used only when the patient has sustained remission from other psychoactive substance dependence.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

F19.21 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.